B CELL MALIGNANCIES
Clinical trials for B CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new B CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for B CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Hard-to-Treat blood cancers in early human trial
Disease control OngoingThis early-stage trial tests an experimental oral drug called ABBV-525 in people with B-cell blood cancers like lymphoma and leukemia. The study aims to find a safe dose and check for side effects. About 78 adults will take the drug in different dose groups over up to 64 months.
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 24, 2026 01:01 UTC
-
Cancer drug zanubrutinib tested for Long-Term safety in 955 patients
Disease control OngoingThis study looks at the long-term safety of the drug zanubrutinib in people with B-cell cancers who were already in a related trial. About 955 participants will continue or start taking zanubrutinib and be monitored for side effects and how well the drug controls their cancer. Th…
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE3 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Cancer patients get continued access to promising drug in rollover study
Disease control OngoingThis study offers continued treatment with the drug parsaclisib (alone or with other drugs) to people with B-cell cancers who were already taking it in an earlier study and were benefiting. The main goal is to check safety and side effects. About 112 participants will take part.
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC